中西医诊治胰腺导管内乳头状黏液性肿瘤研究进展
Research Progress in Diagnosis and Treatment of Intraductal Papillary Mucinous Neoplasm of the Pancreas by Integrated Traditional Chinese and Western Medicine
DOI: 10.12677/tcm.2025.1411671, PDF,    科研立项经费支持
作者: 孙家宝, 郑晨露:天津中医药大学研究生院,天津;孙凯隆:安阳市中医院,安阳 河南;王可仪, 王毓麟*:天津市中医药研究院附属医院消化科,天津
关键词: 胰腺导管内乳头状黏液性肿瘤中西医结合诊治临床管理Intraductal Papillary Mucinous Neoplasm of the Pancreas Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment Clinical Management
摘要: 胰腺导管内乳头状黏液性肿瘤是起源于胰腺导管上皮的囊性肿瘤,以分泌黏液为特征,具有潜在恶变风险。西医的诊治主要以影像学评估、病理分型及手术指征判断为核心,但对于良性或者交界性病变的随访管理、术后并发症防治及抗肿瘤复发等方面仍存在局限性。中医理论将其归属于“积聚”“痞满”等范畴,认为其病机与脾胃虚弱、湿浊瘀毒互结相关。中西医结合诊治胰腺导管内乳头状黏液性肿瘤各有优势又互为补充,将两者充分结合可使IPMN患者受到最大获益。但是目前中西医结合诊治IPMN策略尚未完善。本综述系统梳理了IPMN的西医诊断体系、风险评估及治疗手段,并结合中医理论中的病因病机及治法,从中西医结合角度总结影像、内镜、分子诊断、生物学标志物诊断的优缺点,手术、消融、内镜治疗与中医辨证论治的研究进展,体现中西医结合诊治胰腺导管内乳头状肿瘤的特色优势,概括其诊治IPMN的临床思路。
Abstract: Intraductal Papillary Mucinous Neoplasm (IPMN) of the pancreas is a cystic neoplasm originating from pancreatic ductal epithelium, characterized by mucin secretion and potential malignant transformation. Western medicine diagnosis and treatment mainly focus on imaging evaluation, pathological classification, and judgment of surgical indications, but there are limitations in follow-up management of borderline lesions, prevention and treatment of postoperative complications, and anti-tumor recurrence. In Traditional Chinese Medicine (TCM) theory, IPMN is classified into the categories of “Ji Ju” (abdominal mass) and “Pi Man” (epigastric fullness), with its pathogenesis related to spleen-stomach deficiency and intermingling of dampness-turbidity, blood stasis, and toxin. Diagnosis and treatment of IPMN by integrated traditional Chinese and Western medicine have respective advantages and complement each other, and their full combination can maximize benefits for IPMN patients. However, the strategy of integrating traditional Chinese and Western medicine for IPMN has not yet been perfected. This review systematically combs the diagnostic system, risk assessment, and treatment modalities of IPMN in Western medicine, combines with the etiology, pathogenesis, and therapeutic methods in TCM theory, summarizes the advantages and disadvantages of imaging, endoscopic, molecular diagnostic, and biomarker diagnostic methods from the perspective of integrated medicine, and reviews the research progress of surgery, ablation, endoscopic treatment combined with TCM syndrome differentiation and treatment, so as to reflect the characteristic advantages of integrated traditional Chinese and Western medicine in diagnosing and treating IPMN, and outline its clinical thinking for IPMN management.
文章引用:孙家宝, 郑晨露, 孙凯隆, 王可仪, 王毓麟. 中西医诊治胰腺导管内乳头状黏液性肿瘤研究进展[J]. 中医学, 2025, 14(11): 4648-4658. https://doi.org/10.12677/tcm.2025.1411671

参考文献

[1] Lei, S., Mao, Y., Yang, Q., Yan, H. and Wang, J. (2025) Trends in Pancreatic Cancer Incidence, Prevalence, and Survival Outcomes by Histological Subtypes: A Retrospective Cohort Study. Gastroenterology Report, 13, goaf030. [Google Scholar] [CrossRef] [PubMed]
[2] 薛平, 张大伟. 胰腺导管内乳头状黏液瘤的外科及内镜治疗[J]. 岭南现代临床外科, 2013, 13(1): 11-13.
[3] Tanaka, M., Fernández-del Castillo, C., Kamisawa, T., Jang, J.Y., Levy, P., Ohtsuka, T., et al. (2017) Revisions of International Consensus Fukuoka Guidelines for the Management of IPMN of the Pancreas. Pancreatology, 17, 738-753. [Google Scholar] [CrossRef] [PubMed]
[4] Ohtsuka, T., Fernandez-del Castillo, C., Furukawa, T., Hijioka, S., Jang, J., Lennon, A.M., et al. (2024) International Evidence-Based Kyoto Guidelines for the Management of Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreatology, 24, 255-270. [Google Scholar] [CrossRef] [PubMed]
[5] Khalid, A. and Brugge, W. (2007) ACG Practice Guidelines for the Diagnosis and Management of Neoplastic Pancreatic Cysts. The American Journal of Gastroenterology, 102, 2339-2349. [Google Scholar] [CrossRef] [PubMed]
[6] 李家速, 孙洪鑫, 李兆申. 《2023年国际胰腺病协会京都指南: 胰腺导管内乳头状黏液性肿瘤的管理》意见要点[J]. 临床肝胆病杂志, 2024, 40(3): 478-482.
[7] 张传龙, 刘福栋, 姜晓晨, 等. 基于“辨病论治”五步探讨胰腺癌前病变辨治思路[J]. 世界中医药, 2024, 19(5): 687-690.
[8] Oo, J., Brown, L. and Loveday, B.P. (2024) Intraductal Papillary Mucinous Neoplasm: Overview of Management. Australian Journal of General Practice, 53, 835-839. [Google Scholar] [CrossRef] [PubMed]
[9] Jabłońska, B., Szmigiel, P. and Mrowiec, S. (2021) Pancreatic Intraductal Papillary Mucinous Neoplasms: Current Diagnosis and Management. World Journal of Gastrointestinal Oncology, 13, 1880-1895. [Google Scholar] [CrossRef] [PubMed]
[10] Dumlu, E.G., Karakoç, D. and Özdemir, A. (2015) Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current Perspectives. International Surgery, 100, 1060-1068. [Google Scholar] [CrossRef] [PubMed]
[11] AbuDalu, M., Munz, Y. and Ohana, G. (2023) Pancreatico-Gastric Fistula Arising from IPMN Associated with Ductal Adenocarcinoma of the Pancreas: A Case Report and a Literature Review. Frontiers in Surgery, 10, Article ID: 1171234.
[12] Castellano-Megías, V.M., et al. (2014) Pathological Features and Diagnosis of Intraductal Papillary Mucinous Neoplasm of the Pancreas. World Journal of Gastrointestinal Oncology, 6, 311-324. [Google Scholar] [CrossRef] [PubMed]
[13] Yamashige, D., Hijioka, S., Shimizu, Y., Yanagisawa, A., Nakamura, M., Hara, K., et al. (2025) Clinical Impact of Epithelial Types on Postoperative Outcomes for Intraductal Papillary Mucinous Neoplasms: A Multicenter Retrospective Study. Journal of Gastroenterology, 60, 658-670. [Google Scholar] [CrossRef] [PubMed]
[14] Keane, M.G. and Afghani, E. (2021) A Review of the Diagnosis and Management of Premalignant Pancreatic Cystic Lesions. Journal of Clinical Medicine, 10, Article No. 1284. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, T.T., Sadler, T.J., Whitley, S., Brais, R. and Godfrey, E. (2019) The CT Fish Mouth Ampulla Sign: A Highly Specific Finding in Main Duct and Mixed Intraductal Papillary Mucinous Neoplasms. The British Journal of Radiology, 92, Article ID: 20190461. [Google Scholar] [CrossRef] [PubMed]
[16] 浦宁, 刘亮, 楼文晖, 等. 2023年版《国际胰腺病协会京都指南: 胰腺导管内乳头状黏液性肿瘤的管理》更新要点及解读[J]. 中国实用外科杂志, 2024, 44(5): 497-505.
[17] Heckler, M., Brieger, L., Heger, U., Pausch, T., Tjaden, C., Kaiser, J., et al. (2018) Predictive Performance of Factors Associated with Malignancy in Intraductal Papillary Mucinous Neoplasia of the Pancreas. BJS Open, 2, 13-24. [Google Scholar] [CrossRef] [PubMed]
[18] Nista, E.C., Schepis, T., Candelli, M., Giuli, L., Pignataro, G., Franceschi, F., et al. (2021) Humoral Predictors of Malignancy in IPMN: A Review of the Literature. International Journal of Molecular Sciences, 22, Article No. 12839. [Google Scholar] [CrossRef] [PubMed]
[19] Seyithanoglu, D., Durak, G., Keles, E., Medetalibeyoglu, A., Hong, Z., Zhang, Z., et al. (2024) Advances for Managing Pancreatic Cystic Lesions: Integrating Imaging and AI Innovations. Cancers, 16, Article No. 4268. [Google Scholar] [CrossRef] [PubMed]
[20] 卓敏玲, 俞悦, 张秀娟, 等. 胰腺导管内乳头状黏液性肿瘤超声检查与MRI诊断效能比较研究[J]. 医学影像学杂志, 2022, 32(8): 1334-1336.
[21] 陈晴, 原春辉. 胰腺导管内乳头状黏液性肿瘤诊疗进展[J]. 中国微创外科杂志, 2018, 18(9): 830-834.
[22] Perez-Johnston, R., Narin, O., Mino-Kenudson, M., Ingkakul, T., Warshaw, A.L., Fernandez-del Castillo, C., et al. (2013) Frequency and Significance of Calcification in IPMN. Pancreatology, 13, 43-47. [Google Scholar] [CrossRef] [PubMed]
[23] Kim, M.C., Kim, J.H., Jeon, S.K. and Kang, H. (2024) CT Findings and Clinical Effects of High Grade Pancreatic Intraepithelial Neoplasia in Patients with Intraductal Papillary Mucinous Neoplasms. PLOS ONE, 19, e0298278. [Google Scholar] [CrossRef] [PubMed]
[24] 顾松旺, 黄鉴和. 多层螺旋CT与磁共振成像对胰腺导管内乳头状黏液性肿瘤的诊断价值比较[J]. 实用医学影像杂志, 2023, 24(2): 146-149.
[25] 曹晓歌. MSCT与MRI诊断胰腺导管内乳头状黏液性肿瘤价值对比分析[J]. 影像研究与医学应用, 2024, 8(9): 43-45.
[26] Liu, H.J., et al. (2021) The Diagnostic Role of CT, MRI/MRCP, PET/CT, EUS and DWI in the Differentiation of Benign and Malignant IPMN: A Meta-Analysis. Clinical Imaging, 72, 183-193.
[27] Park, H.J., Kim, S., Choi, S.H., Kim, J.H., Lee, S.S., Kim, H.J., et al. (2025) Imaging-Based Surveillance in Patients with Initially Detected Pancreatic Cystic Lesions. European Journal of Radiology, 187, Article ID: 112102. [Google Scholar] [CrossRef] [PubMed]
[28] Chiara, M., Federico, B., Cristina, C., et al. (2023) Intraductal Papillary Mucinous Neoplasms of the Pancreas: Uncommon Imaging Presentation, Evolution and Comparison of Guidelines. European Journal of Radiology Open, 11, Article ID: 100531.
[29] 吴志涛, 薛蕴菁. MRI影像学检查在胰腺导管内乳头状黏液性肿瘤相关性浸润癌中的应用价值[J]. 现代医用影像学, 2022, 31(12): 2193-2197.
[30] 王淳正, 许来艳, 侯莉莉. EUS检查与MRCP成像对IPMN良恶性鉴别诊断效能对比[J]. 中国CT和MRI杂志, 2022, 20(5): 139-141.
[31] Huang, C., Prabhu, V., Smereka, P., Vij, A., Anthopolos, R., Hajdu, C.H., et al. (2024) Comparison of Intra-and Inter-Reader Agreement of Abbreviated versus Comprehensive MRCP for Pancreatic Cyst Surveillance. Abdominal Radiology, 49, 3517-3527. [Google Scholar] [CrossRef] [PubMed]
[32] Flammia, F., Fusco, R., Triggiani, S., Pellegrino, G., Reginelli, A., Simonetti, I., et al. (2024) Risk Assessment and Radiomics Analysis in Magnetic Resonance Imaging of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN). Cancer Control, 31. [Google Scholar] [CrossRef] [PubMed]
[33] Kim, W.D., Koo, B., Byun, H.J., et al. (2025) Prediction of Main Pancreatic Duct Involvement in Intraductal Papillary Mucinous Neo-Plasms on Magnetic Resonance Imaging. Abdominal Radiology (New York), 50, 1-10.
[34] 王心悦, 孙力祺, 黄浩杰, 等. 胰腺囊性肿瘤: 超声内镜的诊治研究进展[J]. 海军军医大学学报, 2024, 45(10): 1281-1287.
[35] Ohno, E., Kuzuya, T., Kawabe, N., Nakaoka, K., Tanaka, H., Nakano, T., et al. (2024) Current Status of Endoscopic Ultrasound in the Diagnosis of Intraductal Papillary Mucinous Neoplasms. DEN Open, 5, e413. [Google Scholar] [CrossRef] [PubMed]
[36] Eizaburo, O., Teiji, K., Naoto, K., et al. (2023) Use of Contrast-Enhanced Harmonic Endoscopic Ultrasonography for the Diagnosis of Pancreatic Cystic Lesions. Journal of Medical Ultrasonics (2001), 1-6.
[37] Wesali, S., Molinaro, A., Lindkvist, B., Hedenström, P. and Sadik, R. (2025) Endoscopic Ultrasound Is Useful for the Risk Stratification of Mucinous Pancreatic Cystic Lesions: A Long-Term Prospective Study. Pancreatology, 25, 359-366. [Google Scholar] [CrossRef] [PubMed]
[38] Serinelli, S. and Khurana, K.K. (2024) Intraductal Papillary Mucinous Neoplasms of the Pancreas: Cytologic-Histologic Correlation Study and Evaluation of the Cytologic Accuracy in Identifying High-Grade Dysplasia/Invasive Adenocarcinoma. Cytojournal, 21, 6. [Google Scholar] [CrossRef] [PubMed]
[39] Iwashita, T., Uemura, S. and Shimizu, M. (2023) Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Pancreatic Cystic Lesions: A Comprehensive Review. Journal of Medical Ultrasonics, 51, 219-226. [Google Scholar] [CrossRef] [PubMed]
[40] Yu, S.L., Jie, Z.W., Ye, C.P., et al. (2022) Comparative Performance of Endoscopic Ultrasound-Based Techniques in Patients with Pancreatic Cystic Lesions: A Network Meta-Analysis. American Journal of Gastroenterology, 118, 243-255.
[41] 姜蕾, 令狐恩强, 李惠凯, 等. SpyGlass系统在胰腺囊性肿瘤诊断中的应用[J]. 中华胃肠内镜电子杂志, 2016, 3(1): 33-36.
[42] Terashima, T., Nio, K., Koshikawa, N., Ueno, M., Toyama, T., Miyazawa, M., et al. (2025) Serum Laminin γ2 Monomer as a Novel Diagnostic and Prognostic Marker for Pancreatic Ductal Adenocarcinoma. BJC Reports, 3, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
[43] Jafarnezhad-Ansariha, F., Contran, N., Cristofori, C., Simonato, M., Davanzo, V., Moz, S., et al. (2025) Cystic Fluid Total Proteins, Low-Density Lipoprotein Cholesterol, Lipid Metabolites, and Lymphocytes: Worrisome Biomarkers for Intraductal Papillary Mucinous Neoplasms. Cancers, 17, Article No. 643. [Google Scholar] [CrossRef] [PubMed]
[44] Belfrage, H., Boyd, S., Louhimo, J., Kytölä, S., Johansson, K., Tenca, A., et al. (2024) Next-Generation Sequencing Improves Diagnostic Accuracy of Imaging and Carcinoembryonic Antigen Alone for Pancreatic Cystic Neoplasms. Pancreatology, 24, 1322-1331. [Google Scholar] [CrossRef] [PubMed]
[45] 王婷, 王朝夫, 袁菲. 胰腺导管内乳头状黏液性肿瘤的病理诊断进展[J]. 外科理论与实践, 2024, 29(1): 67-73.
[46] Qadir, I.M., Baril, A.J., Schneider, Y.T.M., et al. (2025) Artificial Intelligence in Pancreatic Intraductal Papillary Mucinous Neo-Plasm Imaging: A Systematic Review.
[47] Jiang, J., Chao, W., Culp, S. and Krishna, S.G. (2023) Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma. Cancers, 15, Article No. 2410. [Google Scholar] [CrossRef] [PubMed]
[48] Lavista Ferres, J.M., Oviedo, F., Robinson, C., Chu, L., Kawamoto, S., Afghani, E., et al. (2024) Performance of Explainable Artificial Intelligence in Guiding the Management of Patients with a Pancreatic Cyst. Pancreatology, 24, 1182-1191. [Google Scholar] [CrossRef] [PubMed]
[49] Tacelli, M., Lauri, G., Tabacelia, D., Tieranu, C.G., Arcidiacono, P.G. and Săftoiu, A. (2025) Integrating Artificial Intelligence with Endoscopic Ultrasound in the Early Detection of Bilio-Pancreatic Lesions: Current Advances and Future Prospects. Best Practice & Research Clinical Gastroenterology, 74, Article ID: 101975. [Google Scholar] [CrossRef] [PubMed]
[50] 赵亮, 尚东, 马跃海, 等. 基于“胰脾一体”观点探讨胰腺疾病的中医辨治[J]. 中医杂志, 2023, 64(16): 1646-1650.
[51] 蒋里, 简婕, 王世东, 等. 胰腺疾病中医病名考辨[J]. 北京中医药, 2020, 39(8): 777-781.
[52] 刘萍, 迟莉丽, 孙大娟. 迟莉丽从“虚毒瘀”论治胰腺导管内乳头状黏液性肿瘤学术思想撷英[J]. 中医临床研究, 2023, 15(34): 129-133.
[53] 张传龙, 王桂彬, 高梦琦, 等. 从肝脾论治胰腺导管内乳头状黏液性肿瘤探微[J]. 北京中医药, 2023, 42(12): 1360-1363.
[54] Marinelli, V., Secchettin, E., Andrianello, S., Moretti, C., Donvito, S., Marchegiani, G., et al. (2020) Psychological Distress in Patients under Surveillance for Intraductal Papillary Mucinous Neoplasms of the Pancreas: The “Sword of Damocles” Effect Calls for an Integrated Medical and Psychological Approach a Prospective Analysis. Pancreatology, 20, 505-510. [Google Scholar] [CrossRef] [PubMed]
[55] 毛艺, 刘苓霜, 沈丽萍. 肿瘤血瘀证及活血化瘀治疗肿瘤研究进展[J]. 河北中医, 2022, 44(11): 1926-1931, 1936.
[56] Hirono, S. and Yamaue, H. (2019) Surgical Strategy for Intraductal Papillary Mucinous Neoplasms of the Pancreas. Surgery Today, 50, 50-55. [Google Scholar] [CrossRef] [PubMed]
[57] 胡海涛, 田艳涛. 胰腺导管内乳头状黏液性肿瘤的外科治疗进展[J]. 中国医刊, 2020, 55(2): 126-129.
[58] Pastier, C., De Ponthaud, C., Nassar, A., Soubrane, O., Mazzotta, A.D., Souche, F., et al. (2025) Laparoscopic Pancreatic Enucleation: How Far Should We Go for Parenchyma Preservation? A Study by the French National Association of Surgery. Surgical Endoscopy, 39, 1696-1708. [Google Scholar] [CrossRef] [PubMed]
[59] Uchihara, D., Shimajiri, S., Harada, Y., Kumamoto, K., Oe, S., Miyagawa, K., et al. (2025) Long-Chain Fatty Acyl CoA Synthetase 4 Expression in Pancreatic Cancer: A Marker for Malignant Lesions and Prognostic Indicator for Recurrence. Diagnostic Pathology, 20, Article No. 59. [Google Scholar] [CrossRef] [PubMed]
[60] Kumano, R., Ohno, E., Ishikawa, T., Yamao, K., Mizutani, Y., Iida, T., et al. (2025) Prognostic Role of Enhancing Mural Nodules in Intraductal Papillary Mucinous Neoplasms with High-Risk Stigmata. Annals of Surgery. [Google Scholar] [CrossRef] [PubMed]
[61] Park, J., Kim, J.H., Ryu, R.R. and Hwang, S. (2025) Important Radiological and Clinicopathological Risk Factors for the Recurrence of Intraductal Papillary Mucinous Neoplasms after Surgical Resection. European Radiology, 35, 5004-5016. [Google Scholar] [CrossRef] [PubMed]
[62] Teoh, A.Y., Seo, D.W., Brugge, W., Dewitt, J., Kongkam, P., Linghu, E., et al. (2019) Position Statement on EUS-Guided Ablation of Pancreatic Cystic Neoplasms from an International Expert Panel. Endoscopy International Open, 7, E1064-E1077. [Google Scholar] [CrossRef] [PubMed]
[63] Qing, Q., Deng, X., Deng, X., Mou, T., Li, B., Tan, Y., et al. (2025) A Single-Center Study Examining the Safety and Effectiveness of ERCP with Pancreatoscopy and Endoluminal Radiofrequency Ablation for Main-Duct IPMN Treatment. Scientific Reports, 15, Article No. 5420. [Google Scholar] [CrossRef] [PubMed]
[64] Fadi, Y., Dana, S.A.B., Nir, L., et al. (2022) Endoscopic Ultrasound-Guided Radiofrequency Ablation of Premalignant Pancreatic-Cystic Neoplasms and Neuroendocrine Tumors: Prospective Study. European Journal of Gastroenterology & Hepatology, 34, 1111-1115.
[65] Barthet, M., Giovannini, M., Gasmi, M., Lesavre, N., Boustière, C., Napoleon, B., et al. (2021) Long-Term Outcome after EUS-Guided Radiofrequency Ablation: Prospective Results in Pancreatic Neuroendocrine Tumors and Pancreatic Cystic Neoplasms. Endoscopy International Open, 9, E1178-E1185. [Google Scholar] [CrossRef] [PubMed]
[66] Karaisz, F.G., Elkelany, O.O., Davies, B., Lozanski, G. and Krishna, S.G. (2023) A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions. Diagnostics, 13, Article No. 536. [Google Scholar] [CrossRef] [PubMed]
[67] Hamada, T., Oyama, H., Takahara, N., Nakai, Y. and Fujishiro, M. (2025) Role of Endoscopy in Clinical Management of Intraductal Papillary Mucinous Neoplasms. Journal of Gastroenterology and Hepatology, 40, 1045-1058. [Google Scholar] [CrossRef] [PubMed]
[68] Oyama, H., Tada, M., Takagi, K., Tateishi, K., Hamada, T., Nakai, Y., et al. (2020) Long-Term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms. Gastroenterology, 158, 226-237.e5. [Google Scholar] [CrossRef] [PubMed]
[69] Ma, T. and Liang, T. (2025) Surveillance of Non-Resected Branch-Duct Intraductal Papillary Mucinous Neoplasms: Is a Simplified Algorithm Justified? Hepatobiliary Surgery and Nutrition, 14, 136-139. [Google Scholar] [CrossRef] [PubMed]
[70] 张佳, 施丽婕. 中西医结合治疗胰腺导管内乳头状黏液性肿瘤术后腹泻合并IgG4相关性疾病1例[J]. 基层中医药, 2023, 2(11): 63-66.
[71] 祁冰, 张桂信, 赵亮, 等. SELECT中西医结合微创诊疗理念在胆胰肿瘤诊治中的应用[J]. 临床肝胆病杂志, 2020, 36(12): 2651-2654.
[72] 刘福栋, 李奕, 张曦元, 等. 脾积丸源流探讨与应用现状[J]. 北京中医药, 2022, 41(4): 403-406.
[73] 张传龙, 姜晓晨, 高梦琦, 等. 基于网络药理学和分子对接技术探究脾积丸治疗胰腺癌的分子机制[J]. 现代药物与临床, 2022, 37(5): 961-969.